Study to Find a Safe and Effective Dose of SKI-G-801 in the Treatment of Patients With Acute Myeloid Leukemia (AML)
Clinical trial NCT03564288 · COMPLETED
Trial details
- NCT number
- NCT03564288
- Sponsor
- Oscotec Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-23
- Primary completion
- 2021-09-02
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.